Relationship between A1166C polymorphism of angiotensin II type 1 receptor gene and arteriosclerosis: A protocol for

Zhongping Shi1, Jun Wang, Shanjiang Chen

  • 1Wenzhou Central Hospital, Wenzhou, Zhejiang Province, China.

Medicine
|February 3, 2021
PubMed

Insights

This study systematically evaluates the association between the angiotensin II type 1 receptor (AT1R) gene A1166C polymorphism and arteriosclerosis. Findings will clarify the genetic basis of arteriosclerosis, aiding in understanding its hereditary nature.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Molecular Biology

Background:

  • Arteriosclerosis exhibits a genetic correlation, with the angiotensin II type 1 receptor (AT1R) gene A1166C polymorphism frequently linked to the condition.
  • Existing evidence for this association lacks a robust evidence-based foundation.
  • This systematic review aims to consolidate and evaluate the existing data.

Purpose of the Study:

  • To systematically evaluate the relationship between the AT1R gene A1166C polymorphism and arteriosclerosis.
  • To provide an evidence-based foundation for understanding the genetic predisposition to arteriosclerosis.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (CNKI, Wanfang, VIP, CBM, PubMed, EMBASE, Web of Science, Cochrane Library) up to December 2020.
  • Included observational studies (case-control, cross-sectional, cohort) in English and Chinese were assessed for quality by two independent researchers.
  • Statistical analysis was performed using Stata 16.0 software.

Main Results:

  • Pulse wave velocity will be utilized as a key indicator for assessing arteriosclerosis.
  • The study will analyze the correlation between the AT1R gene A1166C polymorphism and arteriosclerosis using collected data.

Conclusions:

  • This systematic review will offer evidence-based insights into the genetic factors contributing to arteriosclerosis.
  • The findings are expected to enhance the understanding of the hereditary components of arteriosclerosis.
Abstract

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
331
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
667
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.0K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.0K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.7K